Asset Details

  • Description:
  • Inhibition activity of the tested compounds shown as remaining activity expressed in percentage of MN02, MN05, MN14, MN36, and triclosan. The standard deviation bars for MN0, MN32, and triclosan were lower than 0.1% thus not visible in the graph
  • License:
  • Rights Managed
  • Rights Holder:
  • John Wiley & Sons, Inc.
  • License Rights Holder:
  • Copyright © 2019 John Wiley & Sons A/S
  • Asset Type:
  • Image
  • Asset Subtype:
  • Chart/Graph
  • Image Orientation:
  • Landscape
  • Image Dimensions:
  • 1992 x 1458
  • Image File Size:
  • 92.2 KB
  • Creator:
  • Mohammad A. Ghattas, Nermin A. Eissa, Francesca Tessaro, Remo Perozzo, Leonardo Scapozza, Dana Obaid, Noor Atatreh
  • Credit:
  • Ghattas, M., Eissa, N., & Tessaro, F. (2019). Structure‐based drug design and in vitro testing reveal new inhibitors of enoyl‐acyl carrier protein reductases. Chemical Biology & Drug Design, 94(2), 1545-1555. https://doi.org/10.1111/cbdd.13536.
  • Collection:
  • Keywords:
  • Restrictions:
  • Property Release:
  • No
  • Model Release:
  • No
  • Purchasable:
  • Yes
  • Sensitive Materials:
  • No
  • Article Authors:
  • Mohammad A. Ghattas, Nermin A. Eissa, Francesca Tessaro, Remo Perozzo, Leonardo Scapozza, Dana Obaid, Noor Atatreh
  • Article Copyright Year:
  • 2019
  • Publication Volume:
  • 94
  • Publication Issue:
  • 2
  • Publication Date:
  • 08/01/2019
  • DOI:
  • https://doi.org/10.1111/cbdd.13536

Click on image to enlarge

Would you like to download this asset? Tell us more and we can generate a quote, license and downloadable file.

Add to Cart